FDA Clears Generic Blood Pressure Medication

 

March 23, 2010

March 23, 2010 – The FDA granted approval for diltiazem hydrochloride extended-release tablets to treat hypertension, which is the generic equivalent to Biovail Laboratories International SRL's Cardizem LA product.

Watson Pharmaceuticals Inc. will produce the generic drug and plans for its immediate release. For the 12-months ending Dec. 31, 2009, Cardizem LA had total U.S. sales of approximately $94.1 million, according to IMS Health.

For more information: www.watson.com